Literature DB >> 8665267

Angiotensin II receptor subtypes and phosphoinositide hydrolysis in rat adrenal medulla.

A Israel1, C Strömberg, K Tsutsumi, M R Garrido, M Torres, J M Saavedra.   

Abstract

Angiotensin II (ANG) receptor subtypes were characterized by quantitative autoradiography after incubation with the ANG agonist [124I]Sar1-ANG in rat adrenal medulla. ANG receptors are highly localized in adrenal medulla. Specific binding was displaced by 4% and by 95% with the AT, receptor blocker losartan and the AT2 receptor competitor CGP 42112A, respectively. Analysis of competition curves indicated relative binding potencies for the AT2 population of CGP 42112A>PD 123319> PD 123177. ANG stimulated +-nositol phosphate formation in a dose-dependent manner in rat adrenal medulla. Losartan at concentrations of 10(-9) to 10(-5) M antagonized the effect of ANG, whereas PD 123177 or PD 123319 had no antagonistic action. However, at a higher concentration (10(-5) M) PD 123177 or PD 123319 potentiated the effect of ANG on InsP1-accumulation. In the presence of PD 123319 (10(-5) M) ANG dose-response curve was shifted to the left with no change in the maximal effect. This affect was blocked by the addition of losartan (10(-5) M). On the contrary, the addition of CGP 42112A (10(-6) M) inhibited ANG-induced increase in InsP1-accumulation. On the other hand, ANG and CGP 42112A reduced basal cyclic GMP formation, this effect was partially reverted by sodium orthovanadate, a phosphotyrosine phosphatase inhibitor. Our results further demonstrate the presence of two ANG receptor subtypes in adrenal medulla: ANG binding to AT, receptor stimulates inositol phospholipid metabolism, whereas ANG binding to AT2 receptors decreases both inositol phosphate production and cGMP formation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8665267     DOI: 10.1016/0361-9230(95)02011-f

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  15 in total

1.  Suggestive evidence of a vesicle-mediated mode of cell degranulation in chromaffin cells. A high-resolution scanning electron microscopy investigation.

Authors:  Enrico Crivellato; Paola Solinas; Raffaella Isola; Domenico Ribatti; Alessandro Riva
Journal:  J Anat       Date:  2010-01-28       Impact factor: 2.610

2.  Effects of losartan on catecholamine release in the isolated rat adrenal gland.

Authors:  Hae-Jeong Noh; Yoon-Sung Kang; Dong-Yoon Lim
Journal:  Korean J Physiol Pharmacol       Date:  2009-08-31       Impact factor: 2.016

Review 3.  Angiotensin II AT2 Receptors Contribute to Regulate the Sympathoadrenal and Hormonal Reaction to Stress Stimuli.

Authors:  J M Saavedra; I Armando
Journal:  Cell Mol Neurobiol       Date:  2017-09-07       Impact factor: 5.046

4.  The subtype 2 of angiotensin II receptors and pressure-natriuresis in adult rat kidneys.

Authors:  K L Liu; M Lo; E Grouzmann; M Mutter; J Sassard
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  Inhibitory effects of olmesartan on catecholamine secretion from the perfused rat adrenal medulla.

Authors:  Hyo-Jeong Lim; Sang-Yong Kim; Dong-Yoon Lim
Journal:  Korean J Physiol Pharmacol       Date:  2010-08-31       Impact factor: 2.016

6.  Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors.

Authors:  H Peng; J Moffett; J Myers; X Fang; E K Stachowiak; P Maher; E Kratz; J Hines; S J Fluharty; E Mizukoshi; D C Bloom; M K Stachowiak
Journal:  Mol Biol Cell       Date:  2001-02       Impact factor: 4.138

Review 7.  Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

8.  Regulation of angiotensin II type 2 receptor gene expression in the adrenal medulla by acute and repeated immobilization stress.

Authors:  Regina Nostramo; Andrej Tillinger; Juan M Saavedra; Ashok Kumar; Varunkumar Pandey; Lidia Serova; Richard Kvetnansky; Esther L Sabban
Journal:  J Endocrinol       Date:  2012-08-21       Impact factor: 4.286

9.  Peripherally administered angiotensin II AT1 receptor antagonists are anti-stress compounds in vivo.

Authors:  Jaroslav Pavel; Julius Benicky; Yuki Murakami; Enrique Sanchez-Lemus; Juan M Saavedra
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

10.  Angiotensin II AT1 receptor blockade decreases lipopolysaccharide-induced inflammation in the rat adrenal gland.

Authors:  Enrique Sanchez-Lemus; Yuki Murakami; Ignacio M Larrayoz-Roldan; Armen J Moughamian; Jaroslav Pavel; Tsuyoshi Nishioku; Juan M Saavedra
Journal:  Endocrinology       Date:  2008-06-12       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.